Article
Glaucoma agents effective in reducing diurnal, trough IOPs
Charleston, SC-When prescribing brimonidine 0.2% b.i.d. as monotherapy for ocular hypertension or primary open-angle glaucoma, physicians should make sure that the drug maintains its effectiveness in the late afternoon and may want to add a third drop to the daily dosage, said William C. Stewart, MD.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
